Shannon Morris serves as Chief Medical Officer at Erasca, Inc., where they oversee executive responsibilities. Since joining the company, Shannon Morris has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 29, 2026 involved receiving (via award) 625,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 29, 2026 | ERAS | $0 | Award | 625,000 | $N/A | Discretionary |
Shannon Morris currently holds 625,000 shares of Erasca, Inc. (ERAS), valued at approximately $0. This represents their equity stake as Chief Medical Officer.
Based on SEC Form 4 filings, Shannon Morris has been a net neutral trader of ERAS stock. They have purchased $0 and sold $0 worth of shares.
Shannon Morris's most recent insider trade was on Jan 29, 2026, when they sold 625,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted